Results 41 to 50 of about 1,118 (175)

Liquid biopsy for molecular characterization of diffuse large B‐cell lymphoma and early assessment of minimal residual disease

British Journal of Haematology, Volume 205, Issue 1, Page 109-121, July 2024.
Circulating tumour DNA (ctDNA) is the leading liquid biopsy approach in lymphomas. Our targeted next‐generation sequencing panel detecting specific diffuse large B‐cell lymphoma markers (mutations, translocations and gene rearrangements) provided not only a comprehensive molecular portrait of the lymphoma at diagnosis (n = 68) but also specific tumour ...
Miguel Alcoceba, James P. Stewart, María García‐Álvarez, Luis G. Díaz, Cristina Jiménez, Alejandro Medina, M. Carmen Chillón, Jana Gazdova, Oscar Blanco, Francisco J. Díaz, María J. Peñarrubia, Silvia Fernández, Carlos Montes, Almudena Cabero, María D. Caballero, Ramón García‐Sanz, Marcos González, David González, Pilar Tamayo, Norma C. Gutiérrez, Alejandro Martín García‐Sancho, M. Eugenia Sarasquete   +21 more
wiley   +1 more source

Características imaginológicas del linfoma primario de recto: reporte de un caso y revisión de la literatura

Revista Universitas Medica, 2010
El linfoma primario de recto es un tumor intestinal, poco frecuente, que está constituido, principalmente, por el tipo no Hodgkin extraganglionar y corresponde de 0,2% a 0,6% de todos los tumores de colon y recto.
LIDA MILENA APONTE
doaj  

Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation

Cancer, Volume 130, Issue 12, Page 2205-2214, 15 June 2024.
Abstract Background Patients undergoing autologous hematopoietic cell transplantation (HCT) have a >2‐fold risk of developing cardiovascular disease (CVD; heart failure, myocardial infarction, and stroke), compared to the general population. Coronary artery calcium (CAC) is predictive of CVD in nononcology patients but is not as well studied in ...
Stephanie Wu, June‐Wha Rhee, Aleksi Iukuridze, Alysia Bosworth, Sitong Chen, Liezl Atencio, Venkat Manubolu, Rusha Bhandari, Faizi Jamal, Matthew Mei, Alex Herrera, Fatima Rodriguez, Stephen Forman, Ryotaro Nakamura, F. Lennie Wong, Matthew Budoff, Saro H. Armenian   +16 more
wiley   +1 more source

Revisiting beta‐2 microglobulin as a prognostic marker in diffuse large B‐cell lymphoma

Cancer Medicine, Volume 13, Issue 12, June 2024.
Beta‐2 microglobulin (β2M) has been sporadically incorporated in prognostic models for diffuse large B‐cell lymphoma (DLBCL). We compared the prognostic discriminative ability of four existing DLBCL models with International Prognostic Indices. Moreover, we developed and validated a new model from the largest population investigating this marker so far,
Jelena Jelicic, Karen Juul‐Jensen, Zoran Bukumiric, Mikkel Runason Simonsen, Michael Roost Clausen, Ahmed Ludvigsen Al‐Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter Brown, Tarec Christoffer El‐Galaly, Thomas Stauffer Larsen   +11 more
wiley   +1 more source

How receptor tyrosine kinase‐like orphan receptor 1 meets its partners in chronic lymphocytic leukemia

Hematological Oncology, Volume 42, Issue 2, March 2024.
Abstract Chronic lymphocytic leukemia (CLL) is the most common leukemia in western societies, recognized by clinical and molecular heterogeneity. Despite the success of targeted therapies, acquired resistance remains a challenge for relapsed and refractory CLL, as a consequence of mutations in the target or the upregulation of other survival pathways ...
Nayla Mouawad, Edoardo Ruggeri, Guido Capasso, Leonardo Martinello, Andrea Visentin, Federica Frezzato, Livio Trentin   +6 more
wiley   +1 more source

Linfoma óseo primario

Revista de Osteoporosis y Metabolismo Mineral, 2017
La afectación esquelética en los pacientes con linfoma no hodgkiniano (LNH) no es infrecuente. Suele ser una manifestación tardía, y cuando aparece lo hace generalmente de forma secundaria por linfomas en estadio avanzado y con alta carga tumoral.
Rodríguez Duque JC, Núñez Céspedes J, Montes Moreno S, Mazorra Horts R, del Rey Rozas A, Olmos Martínez JM   +5 more
doaj   +1 more source

Antibody targeting of mutant calreticulin in myeloproliferative neoplasms

Journal of Cellular and Molecular Medicine, Volume 28, Issue 5, March 2024.
Overview of pathogenic mechanisms of mutant calreticulin (CALR) in myeloproliferative neoplasms (MPN) and potential ways to target the mutant calreticulin neoantigen by therapeutic monoclonal antibodies (mAb). 1: Mutant calreticulin is secreted and functions as an immunosuppressor. The mutant calreticulin novel C‐terminus is shown in red.
Frederike Kramer, Ann Mullally
wiley   +1 more source

Linfoma primario bilateral de riñón. Reporte de un caso

Gaceta Médica Espirituana, 2016
Fundamento: Presentamos un caso de linfoma renal primario no Hodgkin bilateral de ambos riñones lo cual es infrecuente. Objetivo: Presentar el caso clínico de una paciente que fallece a los cuatro días de su ingreso en el que se descubrió una masa renal
Pedro León Acosta, Yaslin Perdomo Hernando, Yanis Janel Ceballos Nápoles, Rafael Pila Pérez, Rafael Pila Peláez   +4 more
doaj  

Asociación de linfomas malignos con herpes virus I y II

Revista Médica Herediana, 2002
Objetivos: Conocer la prevalencia de la seropositividad para herpes virus I y II en pacientes con linfomas non Hodgkin y su asociación con el linaje celular (B ó T).
Ashley Efraín Alarcon-Rozas, Fernando Salas Sánchez, Karina Villacres Vela, Julio Guevara Guevara   +3 more
doaj  

Criptococosis sistémica en un paciente con linfoma no Hodgkin

Revista de la Asociación Colombiana de Dermatología y Cirugía Dermatológica, 2004
La criptococosis es una infección aguda, subaguda o crónica causada por la levadura encapsulada Criptococcus neoformans, que muestra una marcada predilección por el cerebro, las meninges y los pulmones.
Alvaro Sandoval Salavarrieta, Alvaro Acosta de Hart, Xavier Rueda Cardena, Elkin Omar Peñaranda Cortes   +3 more
doaj